This abnormal processing is also associated with numerous tau post‐translational modifications in AD and other tauopathies,5 including hyperphosphorylation, truncation, misfolding, and the generation of insoluble tau aggregates, in addition to the translocation of tau to dendrites and the soma from the axonal compartment.1, 2. The gene discussed is MAPT; the disease is Alzheimer disease.